Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells

Biochemical and Biophysical Research Communications

Volumn 270, Issue 2, 2000, Pages 415-420

  Ding, Zhihu ^a   Yang, Xiaolong ^a   Pater, Alan ^a   Tang, Shou Ching ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Dr H Bliss Murphy Cancer Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN; PROTEIN BCL X; STAUROSPORINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UTERINE CERVIX;

EID: 0034643253     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2432     Document Type: Article

References (41)

1. Shapiro A. B., Ling V. The mechanism of ATP-dependent multidrug transport by P-glycoprotein. Acta. Physiol. Scand. Suppl. 643:1998;227-234.
2. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta. 1461:1999;347-357.
3. Futscher B. W., Abbaszadegan M. R., Domann F., Dalton W. S. Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem. Pharmacol. 47:1994;1601-1606.
4. Liu R., Page C., Beidler D. R., Wicha M. S., Nunez G. Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model. Am. J. Pathol. 155:1999;1861-1867.
5. el-Deiry W. S. Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr. Opin. Oncol. 9:1997;79-87.
6. Lehne G., Elonen E., Baekelandt M., Skovsgaard T., Peterson C. Challenging drug resistance in cancer therapy-review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997. Acta Oncol. 37:1998;431-439.
7. Eastman A. Activation of programmed cell death by anticancer agents: Cisplatin as a model system. Cancer Cells. 2:1990;275-280.
8. Hickman J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:1992;121-139.
9. Kerr J. F., Winterford C. M., Harmon B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
10. Moreira L. F., Naomoto Y., Hamada M., Kamikawa Y., Orita K. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res. 15:1995;639-644.
11. Hannun Y. A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
12. Chao D. T., Korsmeyer S. J. BCL-2 family: Regulators of cell death. Annu. Rev. Immunol. 16:1998;395-419.
13. Reed J. C. Bcl-2 family proteins. Oncogene. 17:1998;3225-3236.
14. Story M., Kodym R. Signal transduction during apoptosis; implications for cancer therapy. Front. Biosci. 3:1998;d365-d375.
15. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
16. Strasser A., Harris A. W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
17. Sugimoto C., Fujieda S., Seki M., Sunaga H., Fan G. K., Tsuzuki H., Borner C., Saito H., Matsukawa S. Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo. Int. J. Cancer. 82:1999;860-867.
18. NicAmhlaoibh R., Heenan M., Cleary I., Touhey S., O'Loughlin C., Daly C., Nunez G., Scanlon K. J., Clynes M. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA. Int. J. Cancer. 82:1999;368-376.
19. Campos L., Rouault J. P., Sabido O., Oriol P., Roubi N., Vasselon C., Archimbaud E., Magaud J. P., Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 81:1993;3091-3096.
20. Maung Z. T., MacLean F. R., Reid M. M., Pearson A. D., Proctor S. J., Hamilton P. J., Hall A. G. The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Br. J. Haematol. 88:1994;105-109.
21. Mano Y., Kikuchi Y., Yamamoto K., Kita T., Hirata J., Tode T., Ishii K., Nagata I. Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. Eur. J. Cancer. 35:1999;1214-1219.
22. Reed J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol. 7:1995;541-546.
23. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer. 80:1999;827-841.
24. Pisani P., Parkin D. M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer. 83:1999;18-29.
25. Tsutsumi K., Belaguli N., Qi S., Michalak T. I., Gulliver W. P., Pater A., Pater M. M. Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix. Am. J. Pathol. 140:1992;255-261.
26. Yang X., Jin G., Nakao Y., Rahimtula M., Pater M. M., Pater A. Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis. Int. J. Cancer. 65:1996;338-344.
27. Yang X., Ding Z., Pater A. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells. Exp. Cell. Res. 2000.
28. Yang X., Hao Y., Pater M. M., Tang S. C., Pater A. Enhanced expression of anti-apoptotic proteins in human papillomavirus-immortalized and cigarette smoke condensate-transformed human endocervical cells: Correlation with resistance to apoptosis induced by DNA damage. Mol. Carcinog. 22:1998;95-101.
29. Cryns V., Yuan J. Proteases to die for. Genes Dev. 12:1998;1551-1570.
30. Nuñez G., Benedict M. A., Hu Y., Inohara N. Caspases: The proteases of the apoptotic pathway. Oncogene. 17:1998;3237-3245.
31. Stennicke H. R., Jurgensmeier J. M., Shin H., Deveraux Q., Wolf B. B., Yang X., Zhou Q., Ellerby H. M., Ellerby L. M., Bredesen D., Green D. R., Reed J. C., Froelich C. J., Salvesen G. S. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273:1998;27084-27090.
32. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
33. Zamzami N., Brenner C., Marzo I., Susin S. A., Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene. 16:1998;2265-2282.
34. Liu W., Staecker H., Stupak H., Malgrange B., Lefebvre P., Van De Water T. R. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. NeuroReport. 9:1998;2609-2614.
35. Porter A. G., Janicke R. U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:1999;99-104.
36. Henkels K. M., Turchi J. J. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res. 59:1999;3077-3083.
37. Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J. A., Reed J. C. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell. 80:1995;279-284.
38. Yang X., Hao Y., Ferenczy A., Tang S. C., Pater A. Overexpression of anti-apoptotic gene BAG-1 in human cervical cancer. Exp. Cell Res. 247:1999;200-207.
39. L can confer a multidrug resistance phenotype. Blood. 86:1995;1903-1910.
40. L and caspase-3-like proteases. Proc. Natl. Acad. Sci. USA. 95:1998;5724-5729.
41. L expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene. 18:1999;4495-4504.